Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 580-20-1 | MDL No. : | MFCD00016730 |
Formula : | C9H7NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | XCRPPAPDRUBKRJ-UHFFFAOYSA-N |
M.W : | 145.16 | Pubchem ID : | 135426866 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.77 |
TPSA : | 33.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.78 cm/s |
Log Po/w (iLOGP) : | 1.42 |
Log Po/w (XLOGP3) : | 1.98 |
Log Po/w (WLOGP) : | 1.94 |
Log Po/w (MLOGP) : | 1.19 |
Log Po/w (SILICOS-IT) : | 2.01 |
Consensus Log Po/w : | 1.71 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.66 |
Solubility : | 0.317 mg/ml ; 0.00219 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.3 |
Solubility : | 0.725 mg/ml ; 0.005 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.1 |
Solubility : | 0.115 mg/ml ; 0.000791 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.12 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
31.3 %Chromat. | With Ni-modified Beta zeolite In neat (no solvent) for 0.0833333 h; Microwave irradiation; Reflux; Green chemistry | General procedure: General procedure for synthesis of quinolines from anilines and ADA was carried out in Panasonic NN-K5541JF microwave oven reactor equipping a magnetic stirring device. The typical procedures were as follows: ADA (1mmol), excessive anilines (4mmol) and solid catalyst were charged into a round-bottom ask; and then, the mixtures was placed into microwave reactor. The reaction was conducted by continuous microwave irradiation for 1–40 min under refluxing and stirring condition. Finally, the resulting products were determined by GC–MS of Varian Saturn 2200/ CP-3800 gas chromatography–mass spectrometry equipped with two CP8944 capillary columns (VF-5,30m×0.25mm×0.25 μm). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 1 h; Stage #2: at 20℃; for 1 h; |
To a solution of sodium hydride (5.5 g, 137.50 mmol, 60percent) in N,N-dimethylformamide (150 ml) was added quinolin-7-ol (8 g, 55.1 1 mmol). The reaction was stirred for 1 h at 0°C in a water/ice bath. Then CH3I (7.84 g, 55.23 mmol) was added and the solution was stirred for an additional 1 h at room temperature. The reaction was then quenched by the addition of water/ice (700 ml) and extracted with ethyl acetate (3 x 200 ml). The organic layers were combined, dried over anhydrous sodium sulfate, and concentrated in vacuo to give a residue, which was purified by a silica gel column with 6 percent ethyl acetate in petroleum ether to afford 7-methoxyquinoline as a red oil (5.5 g, 63percent).LC/MS (ES, m/z): [M+H]+ 160.0'H-NMR (300 MHz, CDC13): δ 8.84 - 8.86 (m, 1H), 8.07 - 8.11 (m, 1H), 7.70 - 7.73 (t, / = 5.1 Hz, 1H), 7.44 (d, / = 2.4 Hz, 1H), 7.20 - 7.30 (m, 2H), 3.95 (s, 3H) Attorney Docket No. BIOE0009-401-PC |
25% | With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 12 h; Inert atmosphere | To a solution of quinolin-7-ol (5 g, 34.44 mmol) and Cs2CO3 (22.46 g, 68.89 mmol) in DMF (50 mL) was added iodomethane (2.1 mL, 34.44 mmol). The mixture was stirred at 20 °C for12 b under a nitrogen atmosphere. Water (100 mL) was added and the mixture was extracted with EtOAc (5OmL x 3). The combined organic layers were washed with brine (100 mE x 3), dried over anhydrous Na2SO4 and concentrated in vacuo. The cmde residue was purified by silica gel chromatography (petroleum ether EtOAc = 10: 1) to give the title compound (2.0 g, 25percent) as a yellow oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With bromine; acetic acid In dichloromethane at 0 - 5℃; | Step 2: 8-Bromo-7-hydroxyquinoline[0152] To a stirred solution of 7-hydroxyquinoline (59.0 g, 0.406 mol) in AcOH (120 mL) and CH2Cl2 (240 mL) was slowly added bromine (22.9 ml, 0.444 mol) in AcOH (120 ml) while keeping the internal temperature at 0 - 5 0C. The resulting suspension was stirred for 2 h at 0~5 0C, and thendiluted with EtOAc (100 rnL) and filtered. The solid was washed withEtOAc (2 x 20 mL) and dried in vacuo to give 8-bromo-7-hydroxyquinoline (65 g, 76percent). |